Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy

NCT01968941 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT01968941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01968941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Phase 3
Overall status
Completed
Start date
May 7, 2014
Completion date
May 31, 2022
Enrollment
324 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer